Efficacy of a Fixed-Dose Combination of Ibuprofen and Acetaminophen Compared With Individual Monocomponents in Adult Male Subjects With Endotoxin-Induced Fever: A Randomized Controlled Trial

Adult Male ◽

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Randomized Controlled ◽

Dose Combination ◽

Male Subjects

Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-1800-3 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

Chin Kook Rhee ◽

Hye Yun Park ◽

Jeong-Woong Park ◽

Ji-Hyun Lee ◽

Tae-Hyung Kim ◽

...

Keyword(s):

Study Protocol ◽

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Copd Patients ◽

Efficacy and safety of fixed‐dose combination of drotaverine hydrochloride (80 mg) and paracetamol (500 mg) in amelioration of abdominal pain in acute infectious gastroenteritis: A randomized controlled trial

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.14370 ◽

2018 ◽

Vol 33 (12) ◽

pp. 1942-1947

Author(s):

Shiva Narang ◽

Jitender Koli

Keyword(s):

Abdominal Pain ◽

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Infectious Gastroenteritis ◽

Dose Combination ◽

Drotaverine Hydrochloride

Strategies for Nevirapine Initiation in HIV‐Infected Children Taking Pediatric Fixed‐Dose Combination “Baby Pills” in Zambia: A Randomized Controlled Trial

Clinical Infectious Diseases ◽

10.1086/656628 ◽

2010 ◽

Vol 51 (9) ◽

pp. 1081-1089 ◽

Cited By ~ 32

Author(s):

V. Mulenga ◽

A. Cook ◽

A. S. Walker ◽

D. Kabamba ◽

C. Chijoka ◽

...

Keyword(s):

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Randomized Controlled ◽

Figure Labels Transposed in: Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis: The Study C Randomized Controlled Trial

JAMA ◽

10.1001/jama.2011.1329 ◽

2011 ◽

Vol 306 (12) ◽

pp. 1327

Keyword(s):

Pulmonary Tuberculosis ◽

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Regimen ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Roflumilast Treatment In COPD Patients Taking A Fixed-Dose Combination Of Long-Acting ²2 Agonist (LABA) And Inhaled Corticosteroid (ICS): Rationale And Design Of A Prospective Randomized Controlled Trial

10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2946 ◽

2012 ◽

Cited By ~ 1

Author(s):

Gary T. Ferguson ◽

Stephen I. Rennard ◽

Nicola A. Hanania ◽

Haiyuan Zhu ◽

Shahid Siddiqui ◽

...

Keyword(s):

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Inhaled Corticosteroid ◽

Randomized Controlled ◽

Copd Patients ◽

Prospective Randomized Controlled Trial ◽

Dose Combination ◽

Long Acting

18223 Long-term proactive management of psoriasis vulgaris with fixed-dose combination of 0.005% calcipotriene and 0.064% betamethasone dipropionate foam: Results of a phase III randomized controlled trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.919 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB208

Author(s):

Mark Lebwohl ◽

Jean-Philippe Lacour ◽

Monika Liljedahl ◽

Charles Lynde ◽

Marie Holst Mørch ◽

...

Keyword(s):

Psoriasis Vulgaris ◽

Controlled Trial ◽

Betamethasone Dipropionate ◽

Phase Iii ◽

Fixed Dose ◽

Randomized Controlled ◽

Proactive Management ◽

Long-Term Proactive Management of Psoriasis Vulgaris with Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.32 ◽

2020 ◽

Vol 4 (5) ◽

pp. s32

Author(s):

Mark Lebwohl ◽

Jean-Philippe Lacour ◽

Monika Liljedahl ◽

Charles Lynde ◽

Marie H Mørch ◽

...

Keyword(s):

Psoriasis Vulgaris ◽

Controlled Trial ◽

Betamethasone Dipropionate ◽

Phase Iii ◽

Fixed Dose ◽

Randomized Controlled ◽

Proactive Management ◽

Abstract not available.

Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12166 ◽

2014 ◽

Vol 39 (4) ◽

pp. 424-431 ◽

Cited By ~ 5

Author(s):

S. Kim ◽

I.-J. Jang ◽

D. Shin ◽

D. S. Shin ◽

S. Yoon ◽

...

Keyword(s):

Drug Interaction ◽

Adult Male ◽

Interaction Potential ◽

Healthy Adult ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Healthy Adult Male ◽

Dose Combination ◽

Drug Drug Interaction ◽

Male Subjects

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Protease Inhibitor ◽

Controlled Trial ◽

Fixed Dose ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1